跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 142 条关于
“225Ac”
全部
142
临床试验
48
药物
70
机构
0
资讯
24
4年前
Phase 1/2 Trial Investigates 225Ac-J591 and 177Lu-PSMA-I&T Combination in Metastatic Castration-Resistant Prostate Cancer
4年前
Preliminary Data on 225Ac-J591 Shows Promise in Treating mCRPC
去年
Ariceum Therapeutics Presents Promising Data on 225Ac-Satoreotide at EANM 2024
2年前
FDA Grants Fast Track Designation to 225Ac-FL-020 for Metastatic Castration-Resistant Prostate Cancer
11个月前
Ariceum Therapeutics Advances 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer with Novel Radioligand Therapy Approach
去年
Ariceum's 225Ac-Satoreotide Receives FDA Orphan Drug Designation and IND Clearance for SCLC and Merkel Cell Carcinoma
9天前
FDA Clears IND for Full-Life's Actinium-225 c-MET Radioconjugate [225Ac]Ac-FL-261 in Non-Squamous NSCLC
11个月前
Full-Life Technologies Secures $77 Million Series C to Advance Radiopharmaceutical Pipeline and Manufacturing
去年
Bayer Advances Liver Cancer Treatment with First-in-Human Trial of Novel Targeted Alpha Therapy
5个月前
Novel Actinium-225 Radioconjugate Shows Promise Against Treatment-Resistant HER2-Positive Breast Cancer
第 1 页,共 3 页
上一页
下一页